The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study
Guillaume Vial, Noémie Gensous, Hélène Savel, Christophe Richez, Estibaliz Lazaro, Marie‐Elise Truchetet, Fabrice Bonnet, Isabelle Pellegrin, Rodolphe Thiébaut, Patrick Blanco, P. Duffau
Topics & Concepts
ClopidogrelMedicinePlatelet activationPlateletInternal medicineCardiologyGastroenterologyAspirinSystemic Lupus Erythematosus ResearchAntiplatelet Therapy and Cardiovascular DiseasesPlatelet Disorders and Treatments